These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease. Eremin O, Ashby J, Stephens JP. Int J Cancer; 1978 Jan 15; 21(1):35-41. PubMed ID: 342425 [Abstract] [Full Text] [Related]
8. In vitro studies of axillary lymph node cells in patients with breast cancer. Tsakraklides E, Tsakraklides V, Ashikari H, Rosen PP, Siegal FP, Robbins GF, Good RA. J Natl Cancer Inst; 1975 Mar 15; 54(3):549-56. PubMed ID: 1079055 [Abstract] [Full Text] [Related]
10. Surface immunoglobulin positive lymphocytes in human breast cancer tissue and homolateral axillary lymph nodes. Richters A, Kaspersky CL. Cancer; 1975 Jan 15; 35(1):129-33. PubMed ID: 1089036 [Abstract] [Full Text] [Related]
11. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy. Flannery GR, Chalmers PJ, Rolland JM, Nairn RC. Br J Cancer; 1973 Aug 15; 28(2):118-22. PubMed ID: 4542343 [Abstract] [Full Text] [Related]
12. Lymph node anti-tumour effector cell mechanisms in colorectal carcinoma. Werkmeister JA, Pihl E, Flannery GR. Aust J Exp Biol Med Sci; 1981 Apr 15; 59(Pt 2):115-24. PubMed ID: 7259635 [Abstract] [Full Text] [Related]
17. Axillary lymph nodes and serum immunoglobulins in breast cancer. Lee YT, Richters A. J Am Med Womens Assoc (1972); 1977 Dec 15; 32(12):455-6, 461-6. PubMed ID: 201690 [No Abstract] [Full Text] [Related]